生物负担:外基因组及其在癌症进展和转移中的作用
Siddhant Tripathi1, Yashika Sharma1, Dileep Kumar1
1Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University, Pune, Maharashtra, 411038, India.
Current topics in medicinal chemistry
|July 10, 2024
概括
来自瘤的外体,由癌细胞释放的纳米,显示出作为癌症生物标志物和治疗剂的希望. 这些外体可以影响癌症的进展,免疫反应和瘤微环境,提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 免疫学 免疫学 免疫学
背景情况:
- 外体是由包括癌细胞在内的各种细胞类型释放的纳米纤维.
- 瘤衍生外体 (TDE) 含有生物活性物质,可能在癌症进展和生物标志物中发挥作用.
- 外体细胞因其在癌症治疗中的治疗潜力而受到关注.
研究的目的:
- 审查外体生物发生和关键特征.
- 调查TDE对免疫系统,瘤微环境 (TME) 和转移前位形成的影响.
- 讨论外体在癌症治疗中的潜在应用.
主要方法:
- 关于外体生物发生和功能的文献综述.
- 对TDE对癌症发展和免疫调节的影响的研究分析.
- 探索基于外体的治疗策略.
主要成果:
- 外体在癌症中发挥着多方面的作用,影响免疫反应和TME.
- TDEs可以促进癌症的进展和转移.
- 外体体显示出作为药物输送载体的潜力,在免疫疗法和中子捕获疗法 (BNCT) 中.
结论:
- 外体在癌症生物学中具有重要意义,并代表治疗开发的有前途领域.
- 外体细胞可以被设计为癌细胞的生物重编程器.
- 对基于外体的治疗方法的进一步研究可能会彻底改变癌症治疗.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


